Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares OutstandingShares Repurchased
Ratios

Neurocrine Biosciences (NBIX) Long-Term Debt Repayments (2020 - 2023)

Historic Long-Term Debt Repayments for Neurocrine Biosciences (NBIX) over the last 3 years, with Q2 2023 value amounting to -$100000.0.

  • Neurocrine Biosciences' Long-Term Debt Repayments changed N/A to -$100000.0 in Q2 2023 from the same period last year, while for Sep 2024 it was -$100000.0, marking a year-over-year decrease of 10005.35%. This contributed to the annual value of $308.8 million for FY2024, which is N/A changed from last year.
  • Neurocrine Biosciences' Long-Term Debt Repayments amounted to -$100000.0 in Q2 2023.
  • In the past 5 years, Neurocrine Biosciences' Long-Term Debt Repayments ranged from a high of $186.9 million in Q4 2020 and a low of -$100000.0 during Q2 2023
  • Moreover, its 3-year median value for Long-Term Debt Repayments was $100000.0 (2021), whereas its average is $62.3 million.